	Surgical Outcomes from Nationwide Implementation of the International Best-Practice for Locally Advanced Pancreatic Cancer (PREOPANC-4) study. Br J Surg Stoop TF, Seelen LWF, van 't Land FR, Scheepens JCM, Ali M, van der Hout AC, van der Kolk BM, Bonsing BA, Lips DJ, Manusama ER, Willemsen FEJA, Daams F, Kazemier G, Patijn GA, de Hingh IH, Wijsman JH, Schreinemakers J, Erdmann JI, Mieog JSD, Klaase JM, Rietjens JAC, Bosscha K, Beuk LPM, Nijkamp MW, den Dulk M, Kop MPM, Liem MSL, Luyer M, Stommel MWJ, Busch OR, Festen S, Bouwense S, Karsten TM, van Ravens TW, Neumann UP, de Meijer VE, Nieuwenhuijs VB, Draaisma WA, Derksen W, Bollen TL, Groot Koerkamp B, van Eijck CHJ, Quintus Molenaar I, Wolfgang CL, Del Chiaro M, Katz MHG, Hackert T, Wilmink JW, van Santvoort HC, de Wilde RF, Besselink MG, Dutch Pancreatic Cancer Group. PMID: 42329186 [PubMed - as supplied by publisher]
	Undifferentiated Carcinoma With Osteoclast-like Giant Cells of the Pancreas Diagnosed by EUS-Guided Fine-Needle Biopsy. ACG Case Rep J Chiappetta MF, Murgiano M, de Andreis FB, Ciuffini C, Papparella LG, Vadalà di Prampero SF, Fiorani M, Costamagna G, Bulajic M. PMID: 42326455 [PubMed]
	Integrating Network Pharmacology and Clinical Observation to Elucidate the Therapeutic Mechanisms of Yangzheng Xiaoji Decoction in Primary Liver Cancer. Int J Gen Med Yang S, Liu R, Wen S, Wang Y, Tai N, Tian J. PMID: 42325940 [PubMed]
	Potential Role of Liver Transplantation for Child-Pugh Class A Hepatocellular Carcinoma: Prognosis and Medical Expenditure in Japan-A Retrospective Single-Center Study. Hepatol Res Seki A, Chiba T, Yagi S, Horii R, Takata N, Nomura H, Miyazawa M, Hayashi T, Terashima T, Nakanuma S, Okazaki M, Takada S, Yamashita T, Honda M, Takatori H, Shimakami T, Yamashita T. PMID: 42325018 [PubMed - as supplied by publisher]
	Nab-paclitaxel plus S-1 induction chemotherapy for patients with locally advanced pancreatic cancer: a multicenter, open-label phase 2 study. Signal Transduct Target Ther Cao Z, Qiu J, Luo W, Li J, Chen H, Liu Y, Li S, Li F, Yang Y, Cheng Y, Zhang T, Xue H, Bai C, Zhao Y. PMID: 42324245 [PubMed - in process]
	The performance of intraoperative peritoneal washings in detecting pancreatic ductal adenocarcinoma. Cancer Cytopathol Patel SD, Burns WR, VandenBussche CJ. PMID: 42322121 [PubMed - indexed for MEDLINE]
	Unraveling the roles of fibroblast activation proteinâ€‘positive cancerâ€‘associated fibroblasts in cancer: From mechanisms to therapy (Review). Int J Oncol Tao Z, Zhou Z, Wu Y, Hu J. PMID: 42318956 [PubMed - indexed for MEDLINE]
	Clinico-demographic Profile and Diagnostic Modalities in Patients with Pancreatobiliary Malignancy Undergoing Endoscopic Retrograde Cholangiopancreatography in a Tertiary Care Center of Nepal. Kathmandu Univ Med J (KUMJ) Gurung RB, Sharma P, Sapkota P, Katila S, Adhikari S, Chaudhary A. PMID: 42318715 [PubMed - indexed for MEDLINE]
	Insulinoma in pregnancy: a case report and literature review of diagnostic challenges, multidisciplinary management, and therapeutic dilemmas. Front Endocrinol (Lausanne) Zaihan AF, Ahmad Hisham S, Siwalinggam S, Noralam NHAA, Thiruchelvam K, Kow CS. PMID: 42318216 [PubMed - indexed for MEDLINE]
	Post-transcriptional regulation of mRNA stability in pancreatic ductal adenocarcinoma. Front Immunol Wang H, Liu P, Yamasaki J, Harada T, Sakaguchi T, Takimoto T, Saya H, Nagano O, Fukumura K. PMID: 42317311 [PubMed - indexed for MEDLINE]
	Diabetes and Cancer-Specific Survival: A Nationwide Population-Based Cohort Study Across Multiple Cancer Sites. Cancer Rep (Hoboken) Lohi P, Haukka J, Niskanen L, Auvinen A. PMID: 42315350 [PubMed - indexed for MEDLINE]
	Neuropeptide Y in cancer metastasis and chemoresistance. Neuropeptides Krawczyk E, Kitlinska J. PMID: 42314268 [PubMed - as supplied by publisher]
	Early Versus Delayed Pancreatic Enzyme Replacement Therapy After Pancreatic Cancer Surgery: A Real-World Cohort Study. Am J Clin Oncol Dhali A, Biswas J, Khan F, Sharma A, Dahiya DS, Mandal S, Maji M. PMID: 42314023 [PubMed - as supplied by publisher]
	Risk of pancreatic cancer in patients with vitamin D deficiency: a retrospective cohort study. Eur J Cancer Prev Lai YC, Chang LC, Hung KC, Liao SW, Chen IW. PMID: 42312923 [PubMed - as supplied by publisher]
	Breaking Through the Limits: Nanomedicine at the Service of New Drug Combinations to Tackle Pancreatic Cancer. Wiley Interdiscip Rev Nanomed Nanobiotechnol Bincoletto V, Andreana I, Stella B, Modjtahedi N, Arpicco S, Urbinati G. PMID: 42312894 [PubMed - indexed for MEDLINE]
	Engineered Cell Membrane-Coated Nanoparticles: A New Strategy for Pancreatic Cancer Therapy. ACS Pharmacol Transl Sci Zhou K, Zhang Z, Wang B, Zhao C, Zhu H, Liao X, Li Q, Fu S, Tsai HI, Feng G. PMID: 42312159 [PubMed]
	Development and Validation of a Machine Learning Model to Prognosticate Hepatocellular Carcinoma. Aliment Pharmacol Ther Lim RY, Selvakumar V, Syn N, Chen G, Li J, Kyaw ZM, Zhou J, Kim BK, Wijarnpreecha K, Takahashi H, Huang DQ, Liver Cancer Research Network. PMID: 42311172 [PubMed - as supplied by publisher]
	Diagnostic Uncertainty in Pancreatic Masses: The Critical Role of excluding Malignancy in Suspected Autoimmune Pancreatitis. J Investig Med High Impact Case Rep Mahapatra S, Duggal S, Lee BJ, Kalas MA, Guzman J, Rangashamanna V, Konstantinidis I, Fsso, Hakim MN, Elhanafi SE. PMID: 42311080 [PubMed - indexed for MEDLINE]
	Ablative ultra-hypofractionated radiotherapy with surgical GI exclusion as a "functional spacer" for pancreatic cancer: a phase I safety and feasibility study. BMC Cancer Di Y, Xia T, Wang Y, Ren G. PMID: 42310617 [PubMed - as supplied by publisher]
	Primary hepatic gastrinoma as a clinical mimic: Favorable clinical outcomes. Endocrinol Diabetes Nutr (Engl Ed) Sanchis-Pascual D, de Miguel-Rodríguez L, Morillas-Amat P, Hernando J, García-Álvarez A, Landolfi S, Guerrero-Pérez F, Del Olmo-García MI, Capdevila J. PMID: 42309574 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 60492

Page 1 of 3025



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy